COVID Plus MI Confers Poor Prognosis; 1 in 3 Die in Hospital medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
email article
Primary percutaneous coronary intervention (PCI) was feasible for treating COVID-19 patients with ST-segment elevation MI (STEMI), though prognosis is variable, according to a study from the NACMI registry.
COVID-positive STEMI patients had a 36% risk of the primary outcome of a composite of in-hospital death, stroke, recurrent MI, or repeat unplanned revascularization. This was significantly higher than both the 13% risk observed in patients suspected of infection without testing positive, and the 5% risk among matched controls (
P 0.001 for both), reported a group led by Santiago Garcia, MD, of the Minneapolis Heart Institute Foundation in Minnesota.
The elevated risk was driven primarily by differences in in-hospital mortality (33% vs 11% vs 4%, respectively) and stroke (3% vs 2% vs 0%), they noted in the